Results 141 to 150 of about 19,199 (220)

The Impact of Periodontal Therapy on Disease Activity in Patients with Rheumatoid Arthritis and Concomitant Periodontitis: A Systematic Review and Meta-Analysis. [PDF]

J Clin Med
Khennoufa L, Vinhas AS, Benoit J, Costa R, Salazar F, Cabral C, Reis C.   +6 more
europepmc   +1 more source

Sex Differences in Treatment Response to Targeted Therapy in Rheumatoid Arthritis: A Post Hoc Analysis of a Prospective Observational Study. [PDF]

J Korean Med Sci
Choi SR, Nam E, Sung YK, Cho SK.
europepmc   +1 more source

Methotrexate subcutaneous injection for the initial treatment of rheumatoid arthritis can achieve earlier remission compared with oral administration. [PDF]

Med Int (Lond)
Saio Y.
europepmc   +1 more source

Treating to the Target of Das28 < 2.6 in Rheumatoid Arthritis: the Impact of Efficacy on Cost Effectiveness [PDF]

Value in Health, 2014
Alemao, E., Johal, S., Al, M.J., Rutten-van, Mölken M.   +3 more
openaire   +2 more sources

Safety and effectiveness of rituximab biosimilar (Rituximab-GP2013) versus originator in rheumatoid arthritis: real-world evidence from a single center. [PDF]

Clinics (Sao Paulo)
Bayeh B, Reyes-Neira F, Bonfiglioli KR, Aikawa NE, Assad APL, Miossi R, de Souza FHC, Insfran CE, Giardini HAM, Yuki EFN, Franco A, Domiciano DS, de Moraes JCB, Bonfa E, Saad CGS, de Medeiros-Ribeiro AC, Shimabuco AY.   +16 more
europepmc   +1 more source

Fibromyalgia and Central Sensitization in Rheumatoid Arthritis, Psoriatic Arthritis, and Spondyloarthritis: A Systematic Review. [PDF]

Cureus
Eltoum HA, Hashim NTO, Mohammed SA, Hassanelbasri DG, Ahmed A, Alamin MA.   +5 more
europepmc   +1 more source

Prevalence and clinical characteristics of dermatophytosis in rheumatoid arthritis according to DMARD therapy. [PDF]

Sci Rep
Limon M, Yıldırım N, Türsen U, Ay F, Yıldırım ANS.   +4 more
europepmc   +1 more source

Using DAS28 thresholds overestimates RA remission rates [PDF]

Nature Reviews Rheumatology, 2014
openaire   +1 more source

Hematological Indices as Biomarkers in Patients With Rheumatoid Arthritis but Normal ESR/CRP Receiving Biological/Targeted Synthetic DMARDs. [PDF]

Int J Rheum Dis
Jhou JP, Hou YH, Chang YS, Chang JC, Shen WC.   +4 more
europepmc   +1 more source

Predictors of intramuscular glucocorticoid bridge therapy failure in rheumatoid arthritis: a real-world observational study. [PDF]

Ther Adv Musculoskelet Dis
Xie W, Gao D, Huang H, Zhang Z.
europepmc   +1 more source